The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma

Chimeric antigen receptor T (CAR-T) cell therapy is a novel therapy demonstrating durable remissions in patients with refractory or relapsing non-Hodgkin's B-cell lymphoma. Maintaining a patient's nutritional status has been demonstrated to improve outcomes in cancer treatment. However, no...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of human nutrition and dietetics 2023-10, Vol.36 (5), p.2099-2107
Hauptverfasser:	Ahern, Katie, Pham, James, Sanderson, Robin, Correia De Farias, Madson, Walsh, Kevin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Antigens Appetite loss Autografts Body weight Body weight loss Cancer Cancer therapies CD19 antigen Cell therapy Chemotherapy Chimeric antigen receptors Constipation Cytarabine Diarrhea Etoposide Health services Lymphoma Melphalan Mucositis Nausea Neurotoxicity Nutrition Nutritional status Patients Receptors Side effects Stem cell transplantation Stem cells Vomiting Weight loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!